Tod Woolf

Executive Director, Technology Ventures Office

Tod Woolf is a high-skilled professional, who works in Beth Israel Deaconess Medical Center main office of which is in 499. on the position of Executive Director, Technology Ventures Office since 2019. Tod has earned professional experience in more than 11 positions at different companies. Tod Woolf went to the Harvard University and got education there from 1987 to 1991. North Sudbury, Massachusetts is the area, where this expert was known to live. The professional's email address and phone are easily accessed through this website on demand.
Name variants:
Tod Woolf
Last updated Jun 22, 2024

Contact Information

Last Update
Jul 4, 2022
Email
tw**@ipifini.us, tw**@ipifini.com
Location
North Sudbury, MA

Workplace

Beth Israel Deaconess Medical Center
Executive Director, Technology Ventures Office

Boston, MA

Industry

Hospital & Health Care, General Medical and Surgical H

Work History

Executive Director, Technology Ventures Office

330 Brookline Ave, Boston, MA 02215
Lead Technology Ventures Office team that manages intellectual property and technology commercialization activities at Beth Israel Deaconess Medical Center. Supports faculty in the developme...
from Jul 2019

Technology Licensing Officer In Biotechnology at Mit

77 Massachusetts Ave, Cambridge, MA 02139
Work with MIT faculty, students and staff, along with my colleagues at the Technology Licensing Office, to manage intellectual property, establish corporate alliances, spin out companies and...
Nov 2016 — Jul 2019

Co-Founder and Chief Executive Officer at Etagen

ETAGEN's therapeutic platform employs a single chemically modified oligonucleotide for editing at the mRNA or Genome levels. ETAGEN’s Therapeutic Editing™ technology requires only a single a...
Jan 2014 — Sep 2016

Chief Technology Officer

Recruited by founders of antibody therapeutics company to establish business development and company processes. Established first formal strategic plan & budget Secured meetings with each...
Apr 2010 — Jun 2013

Co-Founder, Chief Executive Officer and Sab Member

257 Simarano Dr SUITE 101, Marlborough, MA 01752
Recruited by 2006 Nobel Prize winner Craig Mello to establish a biotechnology spinout of a public company based on his RNAi therapeutic platform. Recruited world class management and advis...
Jul 2006 — Nov 2012

Founder and President

Dec 2004 — Aug 2016

Founder, President and Chief Executive Officer

72 Missouri St, San Francisco, CA 94107
Founded and led biotechnology company from start-up to acquisition by Invitrogen (NASD: LIFE) for $10M. Grew revenues to $5.5M per year with $20K total equity investment. Forged agreements...
Nov 1996 — Jun 2004

Senior Scientist, Founding Management Team

Recruited by scientific founder Doug Melton, Ph.D. to participate in the establishment of the company. Presented research in support of initial $30M corporate partnership with Biogen Help...
Sep 1994 — Nov 1995

Scientist

Rpi
Princeton, NJ
Research Scientist Co-designed RPI’s lead therapeutic RNA compound with chemistry group. Co-invented lead research antisense compound (GeneBlocs) that was spun-out into Atugen, now Silence...
Mar 1993 — Sep 1994

Research Associate

1200 east California Blvd, Pasadena, CA 91106
Professor Leroy Hood’s Laboratory Assisted post-doctoral fellow in mapping T cell receptor and antibody genes Developed two dimensional DNA electrophoresis mapping technique
Sep 1986 — Aug 1987

President

Occupations

Executive
Chairperson
Scientist
Biotechnology Professional
Chief Executive
Biologist
Biological Scientist

Skills

Biotechnology
Pharmaceutical Industry
Drug Discovery
Cell
Biopharmaceuticals
Molecular Biology
Technology Transfer
Business Development
Biochemistry
Protein Chemistry
Assay Development
Drug Development
Commercialization
Lifesciences
Cell Biology
Laboratory
Protein Expression
Genomics
Immunology
R&D
Cell Culture
Clinical Development
Elisa
Protein Purification
Pcr
Dna Sequencing
Start Ups
Management
Science
Bioinformatics
Oncology
Chemistry
Biomarkers
Biomedical Engineering
Dna
Antibodies
Biomarker Discovery
Clinical Trials
Monoclonal Antibodies
Strategy
Cancer
Genetics
Patents
Login